Neoplastic Syndromes, Hereditary
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
67
|
6385
|
0.100 |
None |
1.000 |
106 |
133
|
1999 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
28
|
802
|
0.800 |
None |
0.963 |
85 |
139
|
2001 |
2019 |
Hereditary Breast and Ovarian Cancer Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Endocrine System Diseases
|
Neoplastic Process
|
17
|
2106
|
0.460 |
None |
1.000 |
25 |
6
|
2003 |
2019 |
Nephroblastoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
5
|
48
|
0.100 |
None |
1.000 |
22 |
1
|
1999 |
2014 |
Multiple congenital anomalies
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
237
|
350
|
0.100 |
None |
1.000 |
14 |
1
|
2001 |
2015 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
34
|
314
|
0.500 |
None |
0.964 |
11 |
5
|
2002 |
2017 |
Li-Fraumeni Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2
|
157
|
0.700 |
None |
0.963 |
9 |
4
|
1999 |
2017 |
Sarcoma
|
group |
Neoplasms
|
Neoplastic Process
|
6
|
6
|
0.110 |
None |
1.000 |
1 |
1
|
2004 |
2011 |
leiomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
BREAST AND COLORECTAL CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
7
|
0.100 |
None |
|
0 |
7
|
|
|
increased risk of pancreatic cancer
|
phenotype |
Neoplasms
|
Finding
|
5
|
6
|
0.100 |
None |
|
0 |
2
|
|
|
Polyp of large intestine
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5
|
6
|
0.100 |
None |
|
0 |
1
|
|
|
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
11
|
20
|
0.200 |
None |
0.769 |
0 |
1
|
2003 |
2019 |
Li-Fraumeni Syndrome 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1
|
11
|
0.700 |
None |
1.000 |
0 |
11
|
2001 |
2018 |
Type 1 Papillary Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2
|
3
|
0.100 |
None |
|
0 |
2
|
|
|
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
9
|
11
|
0.100 |
None |
|
0 |
2
|
|
|
COLORECTAL CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
3
|
8
|
0.100 |
None |
|
0 |
1
|
|
|
Carcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
9
|
11
|
0.100 |
None |
|
0 |
1
|
|
|
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2
|
3
|
0.200 |
None |
0.750 |
0 |
1
|
2003 |
2019 |
PROSTATE CANCER, SOMATIC
|
disease |
|
Neoplastic Process
|
6
|
18
|
0.100 |
None |
|
0 |
2
|
|
|
Thymus Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
PROSTATE CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
4
|
6
|
0.100 |
None |
|
0 |
2
|
|
|
BREAST CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
11
|
24
|
0.100 |
None |
|
0 |
4
|
|
|
Diffuse Intrinsic Pontine Glioma
|
disease |
|
Neoplastic Process
|
3
|
3
|
0.100 |
None |
|
0 |
1
|
|
|
B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified
|
disease |
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|